Your session is about to expire
← Back to Search
Crisis Line Support for Suicide Prevention in Alcoholism
N/A
Recruiting
Led By Mark Ilgen, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights
Study Summary
This trial is testing whether a therapy session about thoughts and perceptions of the National Suicide Prevention Lifeline could help people who have experienced a suicidal crisis.
Who is the study for?
This trial is for individuals with a probable alcohol use disorder in the past year, indicated by an AUDIT score of 16 or more. Participants must have attempted suicide within the last year or had suicidal thoughts recently, as shown by certain scores on the Beck scales.Check my eligibility
What is being tested?
The study is testing whether therapy sessions discussing perceptions about using the National Suicide Prevention Lifeline can benefit those who've faced a suicidal crisis and have issues with alcohol.See study design
What are the potential side effects?
Since this trial involves therapy sessions rather than medication, traditional side effects are not expected. However, participants may experience emotional distress when discussing sensitive topics like suicide.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Crisis line utilization
Secondary outcome measures
Suicidal behavior
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Crisis Line Facilitation (CLF)Experimental Treatment1 Intervention
This single-session intervention addresses the individuals' perceived barriers and facilitators of crisis line use during periods of suicidal crisis.
Group II: Enhanced Usual Care (EUC)Active Control1 Intervention
Participants randomized to the EUC condition will receive a brochure (in-person, via email, or via text message) with the NSP Lifeline and a list of outpatient mental health and substance use resources and encouraged to schedule an appointment with a clinical provider if they would like to discuss any current or past symptoms.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Crisis Line Facilitation (CLF)
2016
N/A
~310
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,796 Previous Clinical Trials
6,377,456 Total Patients Enrolled
9 Trials studying Alcoholism
6,961 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
800 Previous Clinical Trials
1,362,497 Total Patients Enrolled
423 Trials studying Alcoholism
985,208 Patients Enrolled for Alcoholism
Mark Ilgen, PhDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
538 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have severe mental health symptoms or cognitive impairment that could make it difficult for you to understand the study information or assessments.You have attempted suicide within the past year or have a history of suicide attempt more than a year ago and have current thoughts of suicide within the past month. This is determined by a test called the Beck Scale for Suicidal Ideation, which measures your thoughts of suicide, or by a test called the Beck Depression Inventory, which measures your level of depression.I do not understand English.
Research Study Groups:
This trial has the following groups:- Group 1: Crisis Line Facilitation (CLF)
- Group 2: Enhanced Usual Care (EUC)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining opportunities to take part in this research endeavor?
"According to the clinicaltrials.gov page for this study, recruitment is ongoing; it was first made available on October 15th 2020 and underwent its last update on July 7th 2022."
Answered by AI
How many participants are engaged in this medical study?
"Affirmative. Clinicaltrials.gov provides evidence that this research trial is currently recruiting participants, and was initially made public on October 15th 2020 with the last update being published on July 7th 2022. The study requires 500 patients at two distinct sites."
Answered by AI
Who else is applying?
What state do they live in?
Michigan
How old are they?
18 - 65
What site did they apply to?
Meridian Health Services
What portion of applicants met pre-screening criteria?
Met criteria
How responsive is this trial?
Typically responds via
Phone Call
Average response time
- < 2 Days
Most responsive sites:
- Meridian Health Services: < 48 hours
Recent research and studies
Share this study with friends
Copy Link
Messenger